Wulf Dietrich Selected Research

Aprotinin (Trasylol)

2/2009	Aprotinin: 1 year on.
11/2008	Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
2/2008	Effects of aprotinin dosage on renal function: an analysis of 8,548 cardiac surgical patients treated with different dosages of aprotinin.
10/2007	Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery.
4/2007	Factor V Leiden does not affect bleeding in aprotinin recipients after cardiopulmonary bypass.
11/2006	High-dose aprotinin in cardiac surgery: is high-dose high enough? An analysis of 8281 cardiac surgical patients treated with aprotinin.
2/2005	Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions.
8/2004	Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wulf Dietrich Research Topics

Disease

19	Hemorrhage 01/2018 - 05/2002
2	Thrombosis (Thrombus) 07/2014 - 07/2009
2	Thrombophilia 01/2011 - 07/2009
2	Renal Insufficiency (Renal Failure) 02/2008 - 11/2006
2	Hypersensitivity (Allergy) 10/2007 - 02/2005
2	Anaphylaxis (Anaphylactic Shock) 10/2007 - 02/2005
1	Cardiac Tamponade 05/2014
1	von Willebrand Diseases (von Willebrand's Disease) 01/2012
1	Congenital Abnormalities (Deformity) 05/2011
1	Hemophilia A (Haemophilia) 05/2011
1	Activated Protein C Resistance (APC Resistance) 07/2009
1	Body Weight (Weight, Body) 11/2006

Drug/Important Bio-Agent (IBA)

8	Aprotinin (Trasylol)FDA Link 02/2009 - 08/2004
2	Fibrinogen (Factor I)FDA Link 01/2018 - 03/2010
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 07/2014 - 11/2008
2	Pharmaceutical PreparationsIBA 07/2014 - 02/2009
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2011 - 07/2009
2	Thrombin FDA Link 05/2011 - 01/2011
2	factor V LeidenIBA 07/2009 - 04/2007
2	CreatinineIBA 02/2008 - 11/2006
2	Peptide Hydrolases (Proteases)FDA Link 10/2007 - 04/2007
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2012
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2012
1	Factor VIII (Coagulation Factor VIII)IBA 05/2011
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2009
1	Tranexamic Acid (AMCA)FDA Link 11/2008
1	prothrombin complex concentrates (PPSB)IBA 11/2008
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 02/2008
1	Kallikreins (Kallikrein)IBA 11/2006
1	Factor VII (Proconvertin)IBA 05/2002

Therapy/Procedure

3	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2009 - 01/2003
1	Salvage Therapy 05/2014
1	Chest Tubes (Chest Tube) 05/2014
1	Plasma Exchange 01/2012
1	Operative Surgical Procedures 01/2012
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 07/2009
1	Cardiac Surgical Procedures 07/2009
1	Endarterectomy (Thromboendarterectomy) 07/2009
1	Anticoagulation Reversal 11/2008
1	Renal Dialysis (Hemodialysis) 02/2008
1	Length of Stay 08/2004
1	Blood Component Transfusion 08/2004